In addition, FOXO3a induces miR-29b-2 and miR-338 expression, which directly inhibits the transcription of VEGFA and NRP1 (a coreceptor of VEGFA), respectively, thereby inhibiting breast cancer metastasis [49]. Here, FOXO3 is linked to breast carcinoma.